General MedicationsINTRAVENOUSStandard
CARBOPLATIN
CARBOPLATIN
Standard Dose
450MG/45ML (10MG/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview CARBOPLATIN is listed in Drugs@FDA under application 219999 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient CARBOPLATIN Form and strength INJECTABLE;INTRAVENOUS - 450MG/45ML (10MG/ML) Sponsor QILU PHARM HAINAN Submission history Latest submission status date: 2026-02-04 00:00:00.
Structured Monograph
Clinical summary
Approval overview CARBOPLATIN is listed in Drugs@FDA under application 219999 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient CARBOPLATIN Form and strength INJECTABLE;INTRAVENOUS - 450MG/45ML (10MG/ML) Sponsor QILU PHARM HAINAN Submission history Latest submission status date: 2026-02-04 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.